Kypolis Onyx Pharmaceuticals Carfilzomib Injection

Get Latest Price
Manufacturer
Onyx Pharmaceuticals
Brand
Kypolis
Strength
60 mg
Packaging Size
1 Vial
Composition
Carfilzomib
KYPROLIS is shown for the treatment of patients with different myeloma who have received somewhere around two earlier treatments including bortezomib and an immunomodulatory operator and have exhibited malady movement on or inside 60 days of fulfilment of the last treatment. KYPROLIS (carfilzomib) for Injection should be directed under the supervision of a certified doctor experienced in the employment of cancer chemotherapeutic operators.
Uses:
- KYPROLIS is a proteasome inhibitor shown for the treatment of patients with various myeloma who have received no less than two earlier treatments including bortezomib and an immunomodulatory operator and have exhibited illness movement on or inside 60 days of fruition of the last treatment.
Side Effects:
- Fever
* Fatigue
* Clogging
* Sickness
* Diarrhoea
* Shortness of breath
* Swelling of the limits
* Low platelet tally and blood platelet levels

Exports To: Japan | Brazil | Singapore | Slovakia | Bulgaria

View Complete Details
Get Latest PriceRequest a quote

G M Global

Mumbai, Maharashtra
4/5 
★★★★★
★★★★★
 (173)
GST27AAQFG0225P1Z0
Verified Supplier
Wholesale Trader
 View Mobile Number 
46% Response Rate
Contact Supplier

Product Details

Company Details

Product Specification

ManufacturerOnyx Pharmaceuticals
BrandKypolis
Strength60 mg
Packaging Size1 Vial
CompositionCarfilzomib

Product Description

KYPROLIS is shown for the treatment of patients with different myeloma who have received somewhere around two earlier treatments including bortezomib and an immunomodulatory operator and have exhibited malady movement on or inside 60 days of fulfilment of the last treatment. KYPROLIS (carfilzomib) for Injection should be directed under the supervision of a certified doctor experienced in the employment of cancer chemotherapeutic operators.


Uses:

  • KYPROLIS is a proteasome inhibitor shown for the treatment of patients with various myeloma who have received no less than two earlier treatments including bortezomib and an immunomodulatory operator and have exhibited illness movement on or inside 60 days of fruition of the last treatment.


Side Effects: 

  • Fever
  • Fatigue
  • Clogging
  • Sickness
  • Diarrhoea
  • Shortness of breath
  • Swelling of the limits
  • Low platelet tally and blood platelet levels

Interested in this product?Get Latest Price from the seller
Contact Seller

About the Company

Year of Establishment2017
Legal Status of FirmPartnership Firm
Nature of BusinessWholesale Trader
Number of Employees11 To 25 People
Annual TurnoverUpto Rs. 50 Lakh
IndiaMART Member SinceMar 2019
GST27AAQFG0225P1Z0
Import Export Code (IEC)03169*****
Exports to Japan | Brazil | Singapore | Slovakia | Bulgaria
Kypolis Onyx Pharmaceuticals Carfilzomib Injection
Kypolis Onyx Pharmaceuticals ...
termsprivacy policy

Seller Contact Details

Kasturi

3rd Floor Gala No.330/331 Western Express Highway Blue Rose Industrial Premises Cooperative Society, Mumbai - 400066, Maharashtra, India

Get Directions
View Mobile No.
Send SMS
Send Email